BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 173325)

  • 1. Adrenal medullary cyclic nucleotide phosphodiesterase: lack of activation by the calcium-dependent regulator.
    Egrie JC; Siegel FL
    Biochem Biophys Res Commun; 1975 Nov; 67(2):662-9. PubMed ID: 173325
    [No Abstract]   [Full Text] [Related]  

  • 2. Regulation of the high Km cyclic nucleotide phosphodiesterase of adrenal medulla by the endogenous calcium-dependent-protein activator.
    Uzunov P; Gnegy ME; Revuelta A; Costa E
    Biochem Biophys Res Commun; 1976 May; 70(1):132-8. PubMed ID: 179545
    [No Abstract]   [Full Text] [Related]  

  • 3. Protein activator of cyclic 3':5'-nucleotide phosphodiesterase of bovine or rat brain also activates its adenylate cyclase.
    Cheung WY; Bradham LS; Lynch TJ; Lin YM; Tallant EA
    Biochem Biophys Res Commun; 1975 Oct; 66(3):1055-62. PubMed ID: 170936
    [No Abstract]   [Full Text] [Related]  

  • 4. Calcium-dependent cyclic nucleotide phosphodiesterase from brain: comparison of adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate as substrates.
    Brostrom CO; Wolff DJ
    Arch Biochem Biophys; 1976 Jan; 172(1):301-11. PubMed ID: 175742
    [No Abstract]   [Full Text] [Related]  

  • 5. Adrenal medullary cyclic nucleotide phosphodiesterase. Subcellular distribution, partial purification and regulation of enzyme activity.
    Egrie JC; Siegel FL
    Biochim Biophys Acta; 1977 Aug; 483(2):348-66. PubMed ID: 196651
    [No Abstract]   [Full Text] [Related]  

  • 6. Cyclic nucleotide phosphodiesterases from rat anterior pituitary. Characterization of multiple forms and regulation by protein activator and Ca+.
    Azhar S; Menon KM
    Eur J Biochem; 1977 Feb; 73(1):73-82. PubMed ID: 190011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclic nucleotide phosphodiesterases of rabbit renal cortex. Characterization of brush border membrane activities.
    Filburn CR; Sacktor B
    Arch Biochem Biophys; 1976 May; 174(1):249-61. PubMed ID: 7201
    [No Abstract]   [Full Text] [Related]  

  • 8. Cyclic nucleotide phosphodiesterase from a particulate fraction of rat brain. Evidence for an activator deficient form.
    Lindl T; Chapman G
    Biochem Biophys Res Commun; 1976 Aug; 71(4):1273-82. PubMed ID: 9937
    [No Abstract]   [Full Text] [Related]  

  • 9. Reciprocal changes in Ca2+/protein activator-dependent and-independent cyclic AMP phosphodiesterase during the development of chick embryos.
    Tanigawa Y; Shimoyama M; Tai J; Fujii K; Ueda I
    Biochem Biophys Res Commun; 1976 Nov; 73(1):19-24. PubMed ID: 187189
    [No Abstract]   [Full Text] [Related]  

  • 10. The distribution of the Ca++-dependent protein activator of cyclic nucleotide phosphodiesterase in invertebrates.
    Waisman D; Stevens FC; Wang JH
    Biochem Biophys Res Commun; 1975 Aug; 65(3):975-82. PubMed ID: 168896
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of Ca++ on cyclic nucleotide phosphodiesterases of superior cervical ganglion.
    Boudreau RJ; Drummond GI
    J Cyclic Nucleotide Res; 1975; 1(4):219-28. PubMed ID: 177462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of trifluoperazine to the calcium-dependent activator of cyclic nucleotide phosphodiesterase.
    Levin RM; Weiss B
    Mol Pharmacol; 1977 Jul; 13(4):690-7. PubMed ID: 18661
    [No Abstract]   [Full Text] [Related]  

  • 13. Activity of imidazole on the hydrolysis of cyclic AMP and cyclic GMP by bovine heart and rat liver cyclic nucleotide phosphodiesterases.
    Donnelly TE
    Arch Biochem Biophys; 1976 Mar; 173(1):375-85. PubMed ID: 4034
    [No Abstract]   [Full Text] [Related]  

  • 14. Calcium and papaverine interaction with soluble cardiac phosphodiesterase.
    Carpenedo F; Gaion RM; Fassina G
    Biochem Pharmacol; 1975 Nov; 24(22):2069-73. PubMed ID: 174573
    [No Abstract]   [Full Text] [Related]  

  • 15. Cyclic nucleotide hydrolysis in the thyroid gland. General properties and key role in the interrelations between concentrations of adenosine 3':5'-monophosphate and guanosine 3':5'-monophosphate.
    Erneux C; Van Sande J; Dumont JE; Boeynaems JM
    Eur J Biochem; 1977 Jan; 72(1):137-47. PubMed ID: 12974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of the cyclic nucleotide phosphodiesterases in a transplantable pheochromocytoma and adrenal medulla of the rat.
    Levin RM; Weiss B
    Cancer Res; 1978 Apr; 38(4):915-20. PubMed ID: 205349
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibitory and activators of cyclic nucleotide phosphodiesterase.
    Chasin M; Harris DN
    Adv Cyclic Nucleotide Res; 1976; 7():225-64. PubMed ID: 188316
    [No Abstract]   [Full Text] [Related]  

  • 18. Properties of the activator-dependent cyclic nucleotide phosphodiesterase from bovine heart.
    Donnelly TE
    Biochim Biophys Acta; 1977 Jan; 480(1):194-203. PubMed ID: 188479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclic 3':5'-nucleotide phosphodiesterase. Ca2+ confers more helical conformation to the protein activator.
    Liu YP; Cheung WY
    J Biol Chem; 1976 Jul; 251(14):4193-8. PubMed ID: 180019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional, cellular and subcellular distribution of calcium-activated cyclic nucleotide phosphodiesterase and calcium-dependent regulator in porcine brain.
    Egrie JC; Campbell JA; Flangas AL; Siegel FL
    J Neurochem; 1977 Jun; 28(6):1207-13. PubMed ID: 195013
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.